Submission declined on 9 August 2025 by Qcne (talk).
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
Comment: I'm not seeing the WP:ORGCRIT. qcne (talk) 11:27, 9 August 2025 (UTC)
| Company type | Private |
|---|---|
| Industry | Healthcare |
| Founded | 2021 |
| Founders | Ankur Gigras, Vikas Chauhan, Dr. Aman Priya Khanna[1] |
| Headquarters | Gurugram, Haryana, India |
Area served | India |
Key people | Ankur Gigras (CEO) |
| Parent | Vianam Healthtech Private Limited[2] |
| Website | www |
HexaHealth is an Indian health technology company based in Gurugram, Haryana. Founded in 2021, it operates a platform that uses artificial intelligence to facilitate surgery care coordination, hospital and doctor matching, and patient navigation.[1][3]
History
editHexaHealth was founded in 2021 by Ankur Gigras, Vikas Chauhan, and Dr. Aman Priya Khanna to streamline surgical care, from doctor discovery to postoperative support.[1]
Funding
editIn September 2021, HexaHealth raised ₹33 crore in a seed funding round from Omidyar Network India, Chiratae Ventures, and other investors.[4][5]
In April 2025, it secured US$12 million (approximately ₹101.82 crore) in a Series A round led by Orios Venture Partners and 3one4 Capital, with participation from Enzia Ventures, ITI Growth Opportunities Fund, Chiratae Ventures, and Omidyar Network India.[3][1]
HexaHealth has raised a total of approximately US$25.6 million across five funding rounds as of 2025.[6]
Operations
editIn FY 2024-25, the company enabled nearly 15,000 surgeries worth approximately ₹150 crore, with a cumulative total of over 30,000 surgeries since inception.[3]
As of October 2024, the health tech platform employs approximately 259 people and reported operational revenue of ₹17 crore in FY24.[6]
In 2024, it launched a national liver advisory board to guide surgical referrals.[7]
Research and Surveys
editIn February 2024, HexaHealth surveyed ~1,000 individuals with BMI ≥30 in Bengaluru, Mumbai, and Delhi. The study found increased chronic joint pain and hypertension in obese individuals aged 26+, with 15% of those under 20 in Bengaluru having multiple health conditions. Mumbai showed lower willingness to seek medical treatment (15.97%) compared to NCR (19.71%) and Bengaluru (19.34%). Fitness engagement was highest in Mumbai (40%), while Bengaluru led in fitness gadget use (43%). The CEO of health tech platform, Ankur Gigras, stressed the need for obesity awareness campaigns.[8]
References
edit- ^ a b c d "HexaHealth Raises USD 12 Mn Series A Led by Orios and 3one4 Capital to Transform Surgical Care". Entrepreneur India. 30 April 2025. Retrieved 8 August 2025.
- ^ "India Asset Light Hospital Services Market Report". Grand View Research. Retrieved 13 August 2025.
- ^ a b c Chatterjee, Aneeka (30 April 2025). "HexaHealth closes Series A round of $12 mn to redefine Indian surgical care". Business Standard. Retrieved 8 August 2025.
- ^ "Funding rundown: Apna and MPL newest unicorns of 2021; HexaHealth raises seed funding". CNBC-TV18. 24 August 2021. Retrieved 8 August 2025.
- ^ Staff Reporter (15 September 2021). "HexaHealth raises ₹33 crore from Omidyar, others". The Hindu BusinessLine. Retrieved 8 August 2025.
- ^ a b "HexaHealth - 2025 Company Profile, Team, Funding, Competitors & Financials". Tracxn. 30 June 2025. Retrieved 8 August 2025.
- ^ PTI (23 April 2024). "HexaHealth introduces national liver board to guide patients". ET HealthWorld. Retrieved 8 August 2025.
- ^ Lounge, The (2 February 2024). "Obesity linked to worrying rise in chronic joint pain, hypertension: Study". Live Mint. Retrieved 14 August 2025.
{{cite news}}: CS1 maint: url-status (link)
- in-depth (not just brief mentions about the subject or routine announcements)
- reliable
- secondary
- strictly independent of the subject
Make sure you add references that meet all four of these criteria before resubmitting. Learn about mistakes to avoid when addressing this issue. If no additional references exist, the subject is not suitable for Wikipedia.